Appointment booking for Dr. Robert Lafyatis, MD is currently not available.Dr. Robert Lafyatis, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Robert Lafyatis, MD (he/him) is a Rheumatologist, Internist in Boston, MA with over 19 years of experience. What is your opinion of Dr. Robert Lafyatis, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Robert Lafyatis, MD has received over $84,391 which includes payments from the following companies:
$29,941.43 from UCB SA
$16,583.31 from Boehringer Ingelheim Pharmaceuticals, Inc.
$6,210.56 from Merck Sharp & Dohme Corporation
$6,027.07 from Kyowa Hakko Kirin Co., Ltd
$5,355.85 from E.R. Squibb & Sons, L.L.C.
$4,748.25 from Genentech USA, Inc.
$4,350.00 from Boehringer Ingelheim International GmbH
$3,160.32 from Fidia Pharma USA Inc
$2,961.01 from Biogen Idec Inc.
$1,500.00 from GENZYME CORPORATION
$1,124.00 from Pfizer Inc.
$807.50 from F. Hoffmann-La Roche AG
$750.00 from SANOFI US SERVICES INC.
$512.70 from Genentech, Inc.
$206.67 from Gilead Sciences Inc
$124.80 from Bayer HealthCare Pharmaceuticals Inc.
$28.45 from sanofi-aventis U.S. LLC
Payments received by Dr. Robert Lafyatis, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!